Brief: Imagion Biosystems Entered Joint Development Agreement With Global Cancer Technology
12/08/2021 02:33
Aug 12 (Reuters) - Imagion Biosystems Ltd IBX.AX :
* ENTERED INTO A JOINT DEVELOPMENT AGREEMENT WITH GLOBAL
CANCER
TECHNOLOGY
* AGREEMENT TO DEVELOP GCT'S NOVEL NANOSCINTILLATOR
TECHNOLOGY FOR
TREATMENT OF BREAST CANCER
Source text for Eikon: ID:nASX7btb8C
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt